Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysisVíctor Sapena, María Reig, Marco Enea et al.|Gut|2021Cited by 96
Association of Gene Expression Involving Innate Immunity and Genetic Variation in Interleukin 28B With Antiviral ResponseYasuhiro Asahina, Namiki Izumi|Hepatology|2011Cited by 58
No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populationsHiromi Sawai, Katsushi Tokunaga, Nao Nishida et al.|BMC Medical Genetics|2012Cited by 41
Quantitative measurements of M2BPGi depend on liver fibrosis and inflammationHaruki Uojima, Masashi Mizokami, Takashi Nishimura et al.|Journal of Gastroenterology|2024Cited by 23
Serum Growth Differentiation Factor 15 Can Be a Novel Biomarker to Predict the Prognosis of Patients With Hepatitis C Virus Cirrhosis After Virus EliminationYuta Myojin, Tetsuo Takehara, Hayato Hikita et al.|Hepatology Research|2025Cited by 3